Goals
- Evaluate proposed legislation to understand its impact on interventional cardiologists and our patients.
- Ongoing outreach to federal agencies (evaluate and develop comment letters in response to proposed FDA, CMS, NIH, AHRQ federal regulations, getting to know agencies/outreach to federal agencies, assess existing relationships with agencies).
- Support select new interventional cardiology technologies by advocating for coverage and reimbursement of those technologies, when appropriate to support patient-centered decision making.
- Engage in federal and state-level legislative and regulatory proposals to positively influence the outcome.
- Identifying members who have strong contacts with key members of Congress.
Committee Chair (2023–27)
Arnold H. Seto, MD, MPA, FSCAI
Committee Co-Chair (2025–27)
Molly Szerlip, MD, FSCAI
SHD (2020-29)
Andrew M. Goldsweig, MD, MSc, FSCAI
2025–28
Alexander Craig Fanaroff, MD, MSc, MHS
2026-29
Nkechinyere Ijioma, MBBS, FSCAI
SCAI actively represents its members at the state and federal levels, maintaining regular contact with congressional leaders and key administration officials, tracking critical legislative matters as well as public and private payer issues concerning coverage, coding and reimbursement. We build coalitions while coordinating action on behalf of our members and their patients.